Cytokine Milieu of Atopic Dermatitis Skin Subverts the Innate Immune Response to Vaccinia Virus
- 1 March 2006
- journal article
- Published by Elsevier BV in Immunity
- Vol. 24 (3), 341-348
- https://doi.org/10.1016/j.immuni.2006.02.006
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulenceThe Journal of Experimental Medicine, 2005
- Atopic dermatitisThe Lancet, 2003
- Endogenous Antimicrobial Peptides and Skin Infections in Atopic DermatitisNew England Journal of Medicine, 2002
- The Case for Voluntary Smallpox VaccinationNew England Journal of Medicine, 2002
- Smallpox and BioterrorismNew England Journal of Medicine, 2002
- Cutaneous Injury Induces the Release of Cathelicidin Anti-Microbial Peptides Active Against Group A StreptococcusJournal of Investigative Dermatology, 2001
- Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to MousepoxJournal of Virology, 2001
- Interleukin-4/STAT6 Represses STAT1 and NF-κB-dependent Transcription through Distinct MechanismsJournal of Biological Chemistry, 2000
- Essential role of Stat6 in IL-4 signallingNature, 1996
- Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.JCI Insight, 1994